“PREDICTIVE VALUE OF THE DYNAMIC DETERMINATION OF CIRCULATING TUMOR DNA ON PFS IN PATIENTS WITH EGFR MUTATED NSCLC, WITH OSIMERTINIB THERAPY”. Voprosy onkologii 66, no. 2 (February 1, 2020): 135–142. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1065.